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Abstract 
Glycogenin is the protein primer for glycogen synthesis. By autocatalytic transglucosylation from UDPglucose, it creates a malto-octaose chain 
attached to its Tyr-194. It has been uncertain whether the autocatalysis includes the addition of the first glucose residue to Tyr-194. We now show 
this to be the case. However, we also demonstrate, contrary to a claim by others, that Tyr-194 is not necessary for the catalytic function and activity 
of glycogenin. 
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1. Introduction 
Glycogenin is the autocatalytic protein that primes 
glycogen synthesis [ 1,2]. Transglucosylation from 
UDPglucose creates a malto-octaose priming chain 
linked to Tyr-194 of the protein [3,4]. Here we report on 
the role of Tyr-194 in the autocatalytic function of the 
enzyme. The first glucose residue of the malto-octaose is 
bound to the tyrosine. The second and subsequent glu- 
cose residues are bound to glucose. While it was clear 
that the formation of the glucose-glucose bonds was 
autocatalytic [1,2], it was not clear whether this also 
applied to the glucosylation of the tyrosine or whether 
a separate transglucosylase was involved. Here we dem- 
onstrate that the homogenous recombinant protein does 
glucosylate Tyr-194. The question may also be asked, 
and has been asked by Cao et al. [5], whether Tyr-194 is 
necessary for the catalytic function of glycogenin. To 
probe this question they studied the behavior of 
Tyr+Phe- 194 and Tyr--+Thr- 194 mutant recombinant 
proteins. They found both to be incapable of self-gluco- 
sylation, nor would the Phe-194 mutant protein glucosyl- 
ate a 30-residue synthetic peptide corresponding to the 
sequence of glycogenin around Tyr-194. It was con- 
cluded that ‘tyrosine-194 is essential for function (and) 
activity’. 
Here we report a contrary finding. We have engi- 
neered the same Phe- 194 and Thr- 194 mutants. Both are 
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catalytically active and both can glucosylate an alterna- 
tive acceptor. Tyr-194 is therefore not essential for func- 
tion and activity. 
2. Materials and methods 
2. I. Materials 
All biochemicals were from Sigma or Fischer Scientific Co. unless 
otherwise stated. UDP[“‘C]glucose was from NEN Products. Crystal- 
line isoamylase was a gift from Hayashibara Biochemical Laboratories, 
Hiroshima, Japan. Reagents for SDS-PAGE were from Bio-Rad. Bioc- 
inchonic acid for protein determination with bovine serum albumin as 
standard was obtained from Pierce. The Lambda Zap II rabbit muscle 
cDNA library was obtained from Stratagene. The Genius system 
(Boehringer-Mannheim) was used for chemiluminescent detection dur- 
ing screening of the cDNA library. Sep-Pak C,, cartridges were from 
Millipore. 
2.2. Assays for glycogenin 
In the experiments with isoamylase, to determine the manner in 
which the first glucose residue is added to glycogenin, the degree of 
[‘4C]glucosylation of glycogenin was determined by allowing the pro- 
tein to self-glucosylate at room temperature in the presence of 
UDP[‘4C]glucose and Mn’+, precipitating in 10% trichloroacetic acid 
after 20 min and counting the 14C radioactivity in a scintillation counter 
[l]. Using this assay it was determined that the Phe-194 and Thr-194 
mutants were unable to self-glucosylate to any detectable degree. 
When testing the Phe-194 and Thr-194 mutants for their ability to 
use an alternative glucose acceptor, in comparison with the wild-type 
protein, we employed n-dodecyl B-maltoside (DBM) as the acceptor 
using the glycogenin assay method developed by Manzella et al. [6]. The 
radioglucosylated DBM so formed was isolated for counting of radio- 
activity by absorption to and desorption from Sep-Pak Cl8 cartridges 
as in [6]. The degree of transglucosylation achieved by the three homo- 
geneous recombinant proteins as reported in Fig. 1 was measured using 
1, 2,4 and 10 ng of wild-type and Phe-194 mutant and 5, 7.5 and 10 
ng of Thr-194 mutant glycogenin. The results shown are the averages 
of 2 measurements at each protein concentration, measured after 1 h 
at 37°C. The activities of the three proteins, measured during their 
purification, were also determined with DBM. The values shown in 
Table 1 for the homogeneous proteins are based on the activities for 
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2 ng of wild-type and Phe-194 mutant and 5 ng of Thr-194 mutant. The 
amounts of enzyme assayed in the lysates and after DEAE-Sepharose 
were not greater than that corresponding to 2 or 5 ng of the pure 
proteins. 
2.3. Cloning and mutagenesis of glycogenin cDNA and expression of 
recombinant proteins 
Glycogenin cDNA was isolated from a rabbit muscle cDNA library 
constructed on Lambda ZAP II phage by the standard plaque hybrid- 
ization technique, with detection of positive clones by chemilumin- 
escence. The screening probe was generated by PCR amplification 
utilizing degenerate primers and the cDNA library as a template. The 
mutagenesis was achieved by the ‘megaprimer’ method [8]. The sub- 
cloning of the cDNAs into expression vectors and the expression of the 
proteins were done essentially as described by Viscupic et al. [7] and 
Studier et al. [9]. The sequence of the wild-type cDNA was identical to 
that reported by Viscupic et al. [7]. 
2.4. Purification of the wild-type and mutant forms of glycogenin 
E. coli BL211DE3 cells were transformed with the expression con- 
structs, cultured in M9ZB medium and induced essentially as in [7l. The 
cell pellets from 40-ml bacterial cultures expressing each protein were 
resuspended in 2 ml of lysis buffer (50 mM HEPES, pH 7.5, 2 mM 
CHAPS, 1 mM EDTA, 5 mM dithiothreitol, 0.5 mM phenylmethylsul- 
fonyl fluoride, 0.1 mM N-p-tosyl+lysine chloromethyl ketone, 
0.15 mM pepstatin, 0.2 mM leupeptin, 2 mM benzamidine and 0.5 
mg/ml lysozyme), sonicated and centrifuged at 12,000 rpm for 20 min. 
The supernatants were applied to DEAE-Sepharose columns (30 ml) 
equilibrated with 50 mM HEPES, 2 mM CHAPS (HC). Elution was 
achieved with an ascending radient (150 ml) of NaCl (from 0 to 0.6 M) 
in HC. The fractions (1.5 ml each) containing the recombinant proteins, 
as detected by self-glucosylating activity in the case of the wild-type and 
by SDS-PAGE analysis in the case of the mutant proteins, were pooled. 
After addition of ammonium sulfate to 20% saturation, the samples (5 
ml) were subjected to hydrophobic chromatography on a phenyl- 
Sepharose CL-4B column (8 ml), equilibrated with HC containing 0.15 
M NaCl and ammonium sulfate at 20% saturation (starting buffer). The 
glycogenin proteins were desorbed with HC (100 ml); this elution was 
preceded by a descending radient of starting buffer to HC (150 ml). 
Fractions of 3 ml each were collected. Wild-type glycogenin was de- 
tected by self-glucosylation and then SDS-PAGE and the mutant pro- 
teins by SDS-PAGE after first measuring the optical density of the 
particular fraction at 280 nm to detect protein. Homogeneity by SDS- 
PAGE was the criterion used in combining the final products. 
The transglucosylase activities of the recombinant proteins, relative 
to each other, and at stages in the purification, were measured in the 
original lysates and in the pooled fractions by [‘4C]glucosylation of
DBM (Table 1). 
2.5. Deglycosylation of wild-type glycogenin by isoamylase 
Purified wild-type glycogenin (6.8 pmol) was incubated for 1 h at 
room temperature with 5 PM unlabelled UDPglucose and 5 mM Mn*+ 
in 50 mM Tris-HCl, pH 7.4. This was to allow autoglucosylation to 
become complete. To the 50 ~1 digest was added 50 ~1 of 200 mM 
sodium acetate, pH 4.5, including isoamylase (120 U). After 3 h the pH 
was returned to 7.4 with 2 M Tris-HCl. Mn” was added to 5 mM and 
UDP[‘4C]glucose to 4 PM. Self-glucosylation was allowed to occur 
during 20 min when an equal volume of 20% trichloroacetic acid was 
added to precipitate the glucosylated protein for scintillation counting. 
The results of five such experiments are shown in Table 2, compared 
with the 14C incorporated into glycogenin treated identically other than 
with isoamylase. 
In a second series of experiments, purified wild-type glycogenin 
(20 pmol) was incubated overnight at room temperature with isoamy- 
lase (60 U) in 100 mM sodium acetate, pH 7.0 (50 ~1). Then a mixture 
(50 ~1) of 100 mM Tris HCl buffer, pH 7.4, 10 mM Mn*+ and 4 PM 
UDP[‘4C]glucose was added and incubated for 20 min. One half of the 
digest was precipitated with trichloroacetic acid for counting of “‘C 
radioactivity. The other half was heated at 100°C for 1 min to inactivate 
glycogenin and isoamylase. 1 M sodium acetate buffer, pH 7.0, and 1 M 
calcium chloride were added to give final concentrations of 200 mM 
and 10 mM respectively, together with crystalline pancreatic a-amylase 
(20 U), followed by another 10 U after 10 h. After incubation overnight, 
the 14C radioactivity in the trichloroacetic acid-insoluble residue was 
counted. An identical parallel experiment was performed save for the 
inclusion of isoamylase. The results from four such pairs of digests are 
shown in Table 3. 
3. Results and discussion 
3.1. PuriJication of recombinant proteins 
Induced lysates of E. coli transformed with expression 
plasmids containing the cDNA for rabbit muscle glyco- 
genin and the Phe- 194 and Thr-194 mutants, contained 
8-9 mg of soluble protein/40 ml (Table 1). In a two-step 
column procedure, each protein was purified to homoge- 
neity in yields from 25% (Phe-194) to 30% (Thr-194) and 
50% (wild-type) (Table 1). The degree of purification 
achieved was 2.5. Therefore glycogenin and the mutants 
constituted 40% of the soluble protein in the lysates. 
3.2. Transglucosylase activity of wild-type glycogenin and 
the Phe-194 and Thr-194 mutants 
The recombinant glycogenins under comparison were 
wild-type, Phe-194 and Thr-194 mutant proteins based 
on the sequence for rabbit muscle glycogenin and ex- 
pressed in E. coli. Each was purified to homogeneity. 
We confirmed the report by Cao et al. [5], who have 
also prepared the same three proteins, that the recombi- 
nant wild-type enzyme as isolated is already glucosylated 
and undergoes additional Mn*‘-dependent self-glucosyl- 
ation while the Phe-194 mutant does not, nor, as also 
reported by Cao et al. [5], does the Thr-194 mutant, 
indicating that the alternative hydroxyl group afforded 
by Thr is not a substitute for that in Tyr. 
We posed the question of whether the mutants re- 
tained transglucosylase activity or whether, as concluded 
by Cao et al. [5], Tyr-194 is essential for this function. 
Previously we noted that maltose is inhibitory to self- 
glucosylation, an observation that led us to the discovery 
that several p-nitrophenyl a-maltosaccharides, notably 
the maltoside, as well as the a-glucoside, inhibit self- 
glucosylation in the sense that they act as alternative 
acceptors of the transferred a-glucose [lo]. This type of 
alternative acceptor clearly provided an appropriate 
means of testing whether the mutants could transgluco- 
syslate. Recently Manzella et al. [6] described an even 
more effective alternative acceptor, DBM. That this 
should be such an efficient acceptor was unexpected. It 
had been thought that the much greater inhibition (be- 
cause of being a competing acceptor) by p-nitrophenyl 
a-maltoside vs. maltose was because in the former the 
maltose is entirely in the a-form and is linked to an 
aromatic aglycone which might be mimicking Tyr-194 
[lo]. DBM, however, conforms to neither criterion. 
All three recombinant proteins transglucosylated 
DBM (Table 1, Fig. 1). The concentration-activity 
curves showed upward trends at higher enzyme concen- 
trations. At the lower concentrations the wild-type and 
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Fig. 1. The rates of [‘4C]transglucosylation f dodecyl j!-maltoside by 
recombinant glycogenins utilizing UDP[‘4C]glucose. For conditions, 
see section 2. 
Phe-194 mutant proteins had identical activities. The ac- 
tivity of the Thr-194 mutant was 50% of the others 
(Table 1). Clearly the Phe- and Thr-194 mutants are very 
effective as transglucosylases. 
Elsewhere we will report a detailed comparison of how 
the three recombinant proteins also use the p-nitro- 
phenyl a-saccharides as acceptors. The two mutant pro- 
teins transglucosylate these acceptors with an interesting 
specificity difference from the wild type. 
We have, therefore, demonstrated that the Phe-194 
and Thr-194 mutants of glycogenin are active transglu- 
cosylases and, contrary to the report by Cao et al. [5], 
Tyr-194 is not necessary for transglucosylase activity in 
this protein. The function of the Tyr appears to be 
largely confined to accepting transferred a-glucose resi- 
dues. We may note that the evidence offered by Cao et 
al. f5] for the alleged catalytic inactivity of the Phe-194 
mutant was its inability to glucosylate a synthetic 30-unit 
peptide co~esponding to the region around Tyr-194 in 
glycogenin. However, since the wild-type glycogenin also 
failed to glucosylate the peptide, the conclusion drawn 
by Cao et al. [5] is invalid. 
3.3. ~l~~~s~~a~~~n of Tyr-194 of glyc~genin 
As already noted by Viscupic et al. [7], wild-type re- 
combinant glycogenin is obtained in an already glucosyl- 
ated form. Therefore all the glucose residues, including 
the first, joined to Tyr-194, are added autocatalytically 
or, if not, then E. coli must contain a transglucosylase 
that adds the first glucose to Tyr-194. 
To explore this question, we made use of a property 
we recently discovered in isoamylase, the glycogen- 
debranching enzyme [l 11. Isoamylase hydrolyses not 
only the 1,6-interchain glucosidic linkages of glycogen, 
but, in addition, the bond between the terminal glucose 
and Tyr- 194 of glycogenin. 
Accordingly, we treated the already glucosylated wild- 
type glycogenin with isoamylase in order to create carbo- 
hydrate-free protein. This was then incubated with 
UDPglucose, in comparison with glycogenin not treated 
with isoamylase. If glycogenin can glucosylate its Tyr- 
194, then the isoamylase-treated protein should undergo 
additional glucosylation. 
The experiment presented a technical problem. Iso- 
amylase has a pH optimum of 4.5 at which pH glyco- 
genin is inactivated. We discovered, however, that if the 
isoamylase treatment at pH 4.5 was confined to 3 h at 
room temperature, some activity was retained by the 
glycogenin as seen on return to pH 7.4 and addition of 
UDP[14C]glucose. The results in Table 2, a comparison 
of the relative degrees of [i4C]glucosylation of glycogenin 
held at pH 4.5 with and without treatment with isoamy- 
lase, show clearly that exposure to isoamylase nabled a 
Table 1 
Purification of recombinant glycogenin (wild-type) and two mutant proteins (Phe and Thr mutants) 
Total activity 
@mol ~ucose/~n) 
Total protein (mg) Specific activity 
~mo~~ucose/ 
minlmg protein) 
Yield (8) Purification (fold) 
Wild-type 
Lysate 
DEAE-Seph. 
Phenyl-Seph. 
Phe mutant 
Lysate 
DEAE-Seph. 
Phenyl-Seph. 
Thr mutant 
Lysate 
DEAE-Seph. 
Phenyl-Seph. 
9.4 8.9 1.1 100 1.0 
5.8 3.0 1.9 61 1.7 
4.6 1.1 2.7 49 2.5 
11 8.2 1.3 100 1.0 
7.6 2.8 2.7 69 2.1 
2.8 0.9 3.1 25 2.4 
5.0 a.9 0.56 100 1.0 
3.5 2.6 1.3 70 2.3 
1.5 1.1 1.4 30 2.5 
After purification on DEAE-Sepharose and phenyl-Sepharose, ach protein was homogeneous as seen by SDS-PAGE. 
Table 2 
Effect af isoamylase treatment on the degree of self-glucosylation of 
wild-type recombinant glycogenin 
~I_ 
[‘4CjG~ucose incorporated into glyeogenin 
~~o~rnol glycogenin) 
Untreated Treated 
71 836 
89 680 
49 806 
52 720 
47 870 
Average 62+ 18 770 f 67 
The results depict the degree to which wild-type glycogenin was able 
to glucosylate itself after treatment at pH 4,s in the presence of iso- 
amylase (Treated’) to remove pre-existing rn~ltos~~ha~de chains, and 
after imxbation at pH 4.5 in the absence of isoamylase f”Untreated’). 
Shown are the results of five pairs of experiments. For conditions, see 
section 2, 
ployed was already six glucose residues. However, if 
a-amylase was used to treat glycogenin in which every 
glucose residue in the maltosaccharide chains was 14C- 
labelled, including that attached to Tyr-394, then some 
[ “c]glucose (as a-amylase-resistant glucose or maltose 
residues) must remain attached to the protein. 
BRP& greater (more than 1 Zfold) degree of re-glucosyla- 
tion to occur (Table 2)_ Each sample, prior to treatment 
at pH 45, had been exposed to unlabelled UD~glucose. 
Therefure no re-glucosylation was expected, and Iittle 
occurred, in the absence of isoamylase. 
It could be argued that a-amylase, a common enzyme 
impurity, would have the same effect as isoamylase. We 
already had evidence that the crystalline isoamylase em- 
ployed did not contain this impurity+ This evidence was 
the absence of maltose, a characteristic product of CI- 
amylalysis, from the maltosaccharide chains released by 
treatment of glyeogenin with isoamylase [l I]. 
Accordingly, we allowed glycogenin to undergo self- 
f’4C]glucosylation after treatment with isoamylase. In 
this experiment we kept the glyeogenin at pH 7.0 during 
treatment with isoamylase, at which pH the latter is fee- 
bly active, Then, after incubating with ~D~[14C]glu~ose, 
the glycogenin preparation was treated with a-amylase 
and the [i”CJglucose remaining with the protein was 
measured. An identical sample was treated in the same 
way except for the omission of isoamylase. Once again 
(see Table 3), treatment of glycogeuin with isoamylase, 
vs. no treatment, allowed more subsequent *4C-glucosyl- 
ation to occur (cf. Table 2). (In this experiment here was 
no preincubation with unlabelled UDPglucose.) There 
was also si~i~~antly more a-amylase-resistant [‘“C]glu- 
case than when isoamylase pm-treatment was not ap- 
plied (Table 3). An ‘a-amylase impurity could not be 
responsible for the presence of the additional a-amylase- 
resistant [“C]glucose in isoamylase-treated glycogenin, 
otherwise there would be no difference in the amounts 
of 14C remaining after a-amylase treatment. 
We may conclude that isoamylase treatment of glyco- 
genin had, as expected, created the carbohydrate-free 
protein and that, on being offered UDP[“C]glucose, the 
protein had proceeded to re-glucosylate itself, including 
the first glucose residue, joined to Tyr-194. 
We nevertheless resorted to an additional experiment 
to test for a-amyfase, This was based on the knowledge 
that when native glycogenin, isolated in an already glu- 
cosylated form, is allowed to self-glucosylate with 
UDP[“%JJglucose, mast of the 14C label thereby added 
can be removed by a-amylase [ 1,12,13]. This is because 
m-amylase can shorten the maltosa~~ha~d~ chains of gly- 
cogenia to glucose and maltose residues, where the aver- 
age length of the chains in the glycogenin specimen em- 
Given the knowledge that isoamylase can split both 
glu~syi-glucose and glu~usyl-tyrosine bonds 1111, the 
results of the test for such dual specificity in the case of 
the auto-glucosylation of gtycogenin are not unexpected. 
Nevertheless, the knowledge now gained, that glyco- 
genin is entirely self-sufficient for its own glucosylation, 
is very important because it eliminates a previous area 
of uncertainty at the beginning of glycogen synthesis, 
namely the addition of the very first glucose residue. 
Table 3 
Enhancement of ~~-g~u~osy~ation of &ycogenm by pretreatment with isoamylase: test for ~o~t~in~~on by z-amylase 
fz4CZ]Gfucuse incorporated into gIycogenin (molfmot giycogenin) 
Untreated with isoamylase Treated with isoamylase 
Before El-amylase treatment After cl-amylase treatment Before a-amylase treatment After a-amyiase treatment 
0.86 0.04 1.54 0.18 
0.89 0.13 I*60 0.43 
0.70 0.08 134 0.29 
0.90 0.14 1.45 0.39 
Average 0.84 + 0.09 0.10 -4 0.05 1.48~a.11 0.32 + 0.11 
The results depict the extent of’ self-I’~~glucosylaticrn by wild-type g~yoogenin, treated and not treated with isoamyiase at pH 7.0, followed by 
treatment of the ~~4~g~u~sy~~ted protein with a-amylase ts learn how much ‘V was resistant o cr-amylase. These are the results of four se& of 
experiments. For conditions, see section 2. 
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